In today’s recent session, 21.37 million shares of the Vivos Therapeutics Inc (NASDAQ:VVOS) have been traded, and its beta is 7.70. Most recently the company’s share price was $3.71, and it changed around $0.91 or 32.50% from the last close, which brings the market valuation of the company to $12.61M. VVOS at last check was trading at a discount to its 52-week high of $48.79, offering almost -1215.09% off that amount. The share price’s 52-week low was $1.91, which indicates that the recent value has risen by an impressive 48.52% since then. We note from Vivos Therapeutics Inc’s average daily trading volume that its 10-day average is 53740.0 shares, with the 3-month average coming to 63.65K.
Vivos Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended VVOS as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Vivos Therapeutics Inc is expected to report earnings per share of -0.78 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vivos Therapeutics Inc (NASDAQ:VVOS) trade information
Instantly VVOS has been showing a green trend so far today with a performance of 32.50% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.59 on recent trading daydecreased the stock’s daily price by -3.34%. The company’s shares are currently down -70.18% year-to-date, but still up 22.04% over the last five days. On the other hand, Vivos Therapeutics Inc (NASDAQ:VVOS) is 42.70% up in the 30-day period. We can see from the shorts that 56857.0 shares have been sold at a short interest cover period of 1.0 day(s).
Vivos Therapeutics Inc (VVOS) estimates and forecasts
Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 51.90% in revenue this quarter, and will report an increase of 81.00% in the next quarter. The year-over-year growth rate is expected to be 15.30%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 3.93M in revenue for the current quarter. 2 analysts expect Vivos Therapeutics Inc to make 4.38M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 3.3M and 3.25M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 19.10%. Forecasts for the next quarter put sales growth at 34.90%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 3.00%.
VVOS Dividends
Vivos Therapeutics Inc’s next quarterly earnings report is expected to be released on 2024-Nov-12.
Vivos Therapeutics Inc (NASDAQ:VVOS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.93% of Vivos Therapeutics Inc shares, and 5.49% of them are in the hands of institutional investors. The stock currently has a share float of 5.84%.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jul 31, 2024. The former held 16.13 shares worth $56614.0, making up 0.47% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 10.58 shares worth around $37131.0, which represents about 0.31% of the total shares outstanding.
